BioPharma Drug Approval

Innovent Biologics Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medi...

 June 22, 2021 | News

Chinese Bioheng Biotech received ODD from the U.S. FDA

"CTD401 is the first innovative product based on our next-generation generic CAR-T technology platform. It has excellent efficacy and superior safety in ex...

 June 21, 2021 | News

With Serum Institute as a partner, Novavax is poised to launch in India.

The Novavax trials conducted on 29,960 people in the US and Mexico have delivered results that equal the Pfizer NSE -1.09 % and Moderna jabs and do better ...

 June 16, 2021 | News

FDA Approves StrataGraft for the Treatment of Adults with Thermal Burns

Thermal burns are typically caused by direct contact with an external heat source such as steam, scalding water, hot surfaces or fire. "Serious burns can ...

 June 16, 2021 | News

Harbour BioMed and Dana-Farber to Advance Novel Biotherapies for Cancer Treatment

Harbour BioMed scientists and Dana-Farber researchers will be working together to develop novel oncologic drugs, including bispecific antibodies and CAR-T ...

 June 16, 2021 | News

Vicore announces FDA acceptance of C21 in COVID-19

ATTRACT-3 trial is a randomized, double-blind, placebo-controlled, multinational, phase 3 trial that will include 600 adult patients hospitalized with COVI...

 June 14, 2021 | News

FDA Takes Steps to Increase Availability of COVID-19 Vaccine

The agency is announcing today that it is authorizing for use, under the emergency use authorization (EUA) for the Janssen COVID-19 vaccine, two batches of...

 June 12, 2021 | News

FDA’s Decision to Approve New Treatment for Alzheimer’s Disease

This approval is significant in many ways. Aduhelm is the first novel therapy approved for Alzheimer’s disease since 2003. Perhaps more significantly...

 June 09, 2021 | News | By Dr. Patrizia Cavazzoni, Director, FDA Center for Drug Evaluation and Research

FDA Approval of Aducanumab

Neurimmune welcomes the news that the U.S. Food and Drug Administration (FDA) has approved Biogen's regulatory application for the use of aducanumab in the...

 June 08, 2021 | News

Merck’s KEYTRUDA® Given After Surgery Reduced the Risk of Disease Recurrence or Death

First-Time Disease-Free Survival Data to be Presented During Plenary Session at the 2021 ASCO Annual Meeting   Merck’s KEYTRUDA® (pemb...

 June 07, 2021 | News

Samsung Pharm & GemVax present pancreatic cancer immunotherapeutic drug, RIAVAX™

ASCO 2021, which celebrates its 57th anniversary this year, runs from June 4th to June 8th and will be held virtually due to COVID-19. Some ...

 June 07, 2021 | News

China NMPA Approves MicuRx's Contezolid for Treatment of Drug-Resistant Bacterial Infection

By leveraging the proprietary technology platform built for drug discovery and screening, MicuRx R&D team discovered the next-generation oxazolidinone ...

 June 04, 2021 | News

Govt.Of India finalises advance arrangement for Second Made in India Vaccine

Union Ministry of Health finalises advance arrangement with M/s Biological-E Ltd., Hyderabad for 30 cr COVID19 Vaccine doses The COVID-19 vaccine of Biolo...

 June 03, 2021 | News

Cognoa Receives FDA Marketing Authorization for Autism Diagnosis Aid

 – Cognoa, a pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with behavioral health...

 June 03, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close